Beta Bionics Inc (BBNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | |
| Sales | 15,046 | 12,933 | 0 |
| Cost of Goods | 6,962 | 5,732 | N/A |
| Gross Profit | 8,084 | 7,201 | N/A |
| Operating Expenses | 20,830 | 17,386 | 0 |
| Operating Income | -11,784 | -9,453 | N/A |
| Other Income | -2,679 | -2,996 | 0 |
| Pre-tax Income | -14,463 | -12,449 | 0 |
| Net Income Continuous | -14,463 | -12,449 | N/A |
| Net Income | $-14,463 | $-12,449 | $N/A |
| EPS Basic Total Ops | -2.37 | -2.07 | N/A |
| EPS Basic Continuous Ops | -2.37 | -2.07 | N/A |
| EPS Diluted Total Ops | -2.37 | -2.07 | N/A |
| EPS Diluted Continuous Ops | -2.37 | -2.07 | N/A |
| EBITDA(a) | $-11,208 | $-8,890 | $N/A |